Chad A. MirkinPhD
Dr. Chad A. Mirkin is the Director of the International Institute for Nanotechnology, the George B. Rathmann Prof. of Chemistry, Prof. of Chemical and Biological Engineering, Prof. of Biomedical Engineering, Prof. of Materials Science & Engineering, and Prof. of Medicine at Northwestern University. He holds a B.S. degree from Dickinson College (1986, elected into Phi Beta Kappa) and a Ph.D. degree in Chemistry from the Penn. State University (1989). He was an NSF Postdoctoral Fellow at the MIT prior to becoming a professor at Northwestern University in 1991.
Dr. Mirkin is a chemist and a world-renowned nanoscience expert, who is known for his development of nanoparticle-based biodetection and therapeutic schemes, the invention of Dip-Pen Nanolithography, and contributions to supramolecular chemistry, nanoelectronics and nano-optics. He is the author of over 590 manuscripts and 930 patent applications (251 issued), and the founder of Nanosphere, Inc., AuraSense, LLC, and AuraSense Therapeutics, LLC, companies which are commercializing nanotechnology applications in the life science and semiconductor industries. Dr. Mirkin has been recognized for his accomplishments with over 80 national and international awards, Lemelson MIT Prize. He is a Member of the National Academy of Sciences, the National Academy of Engineering, the Institute of Medicine, and the American Academy of Arts and Sciences, and he is a Fellow of the American Association for the Advancement of Science. Dr. Mirkin has served on the Editorial Advisory Boards of over twenty scholarly journals. He is the founding editor of the journal Small, one of the premier international nanotechnology journals, and he has co-edited three bestselling books on nanobiotechnology. He is a member of the President’s Council of Advisors on Science and Technology (PCAST, Obama Admin).